Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects

A Coşkun, A Carobene, M Kilercik, M Serteser, S Sandberg, AK Aarsand, P Fernandez-Calle, N Jonker, WA Bartlett, J Díaz-Garzón, S Huet, C Klzlltaş, I Dalgaklran, E Ugur, I Unsal, on behalf of the European Biological Variation Study of the EFLM Working Group on Biological Variation

Research output: Contribution to journalArticle

Abstract

The complete blood count (CBC) is used to evaluate health status in the contexts of various clinical situations such as anemia, infection, inflammation, trauma, malignancies, etc. To ensure safe clinical application of the CBC, reliable biological variation (BV) data are required. The study aim was to define the BVs of CBC parameters employing a strict protocol. Blood samples, drawn from 30 healthy subjects (17 females, 13 males) once weekly for 10 weeks, were analyzed using a Sysmex XN 3000 instrument. The data were assessed for normality, trends, outliers and variance homogeneity prior to coefficient of variation (CV)-analysis of variance (ANOVA). Sex-stratified within-subject (CV I ) and between-subjects (CV G ) BV estimates were determined for 21 CBC parameters. For leukocyte parameters, with the exception of lymphocytes and basophils, significant differences were found between female/male CV I estimates. The mean values of all erythrocyte-, reticulocyte- and platelet parameters differed significantly between the sexes, except for mean corpuscular hemoglobin concentration, mean corpuscular volume and platelet numbers. Most CV I and CV G estimates appear to be lower than those previously published. Our study, based on a rigorous protocol, provides updated and more stringent BV estimates for CBC parameters. Sex stratification of data is necessary when exploring the significance of changes in consecutive results and when setting analytical performance specifications. © 2018 Walter de Gruyter GmbH, Berlin/Boston.
Original languageEnglish
Pages (from-to)1309-1318
Number of pages10
JournalClinical Chemistry and Laboratory Medicine
Volume56
Issue number8
DOIs
Publication statusPublished - 2018

Fingerprint

Blood Cell Count
Healthy Volunteers
Blood
Erythrocyte Indices
Platelets
Basophils
Reticulocytes
Berlin
Platelet Count
Lymphocytes
Health Status
Anemia
Analysis of variance (ANOVA)
Analysis of Variance
Leukocytes
Blood Platelets
Erythrocytes
Inflammation
Hemoglobins
Health

Cite this

Coşkun, A., Carobene, A., Kilercik, M., Serteser, M., Sandberg, S., Aarsand, AK., ... Variation, O. B. O. T. E. B. V. S. O. T. EFLM. W. G. O. B. (2018). Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. Clinical Chemistry and Laboratory Medicine, 56(8), 1309-1318. https://doi.org/10.1515/cclm-2017-1155

Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. / Coşkun, A; Carobene, A; Kilercik, M; Serteser, M; Sandberg, S; Aarsand, AK; Fernandez-Calle, P; Jonker, N; Bartlett, WA; Díaz-Garzón, J; Huet, S; Klzlltaş, C; Dalgaklran, I; Ugur, E; Unsal, I; Variation, on behalf of the European Biological Variation Study of the EFLM Working Group on Biological.

In: Clinical Chemistry and Laboratory Medicine, Vol. 56, No. 8, 2018, p. 1309-1318.

Research output: Contribution to journalArticle

Coşkun, A, Carobene, A, Kilercik, M, Serteser, M, Sandberg, S, Aarsand, AK, Fernandez-Calle, P, Jonker, N, Bartlett, WA, Díaz-Garzón, J, Huet, S, Klzlltaş, C, Dalgaklran, I, Ugur, E, Unsal, I & Variation, OBOTEBVSOTEFLMWGOB 2018, 'Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects', Clinical Chemistry and Laboratory Medicine, vol. 56, no. 8, pp. 1309-1318. https://doi.org/10.1515/cclm-2017-1155
Coşkun, A ; Carobene, A ; Kilercik, M ; Serteser, M ; Sandberg, S ; Aarsand, AK ; Fernandez-Calle, P ; Jonker, N ; Bartlett, WA ; Díaz-Garzón, J ; Huet, S ; Klzlltaş, C ; Dalgaklran, I ; Ugur, E ; Unsal, I ; Variation, on behalf of the European Biological Variation Study of the EFLM Working Group on Biological. / Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. In: Clinical Chemistry and Laboratory Medicine. 2018 ; Vol. 56, No. 8. pp. 1309-1318.
@article{2ed826c7a66f43d6afc7270ece48267f,
title = "Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects",
abstract = "The complete blood count (CBC) is used to evaluate health status in the contexts of various clinical situations such as anemia, infection, inflammation, trauma, malignancies, etc. To ensure safe clinical application of the CBC, reliable biological variation (BV) data are required. The study aim was to define the BVs of CBC parameters employing a strict protocol. Blood samples, drawn from 30 healthy subjects (17 females, 13 males) once weekly for 10 weeks, were analyzed using a Sysmex XN 3000 instrument. The data were assessed for normality, trends, outliers and variance homogeneity prior to coefficient of variation (CV)-analysis of variance (ANOVA). Sex-stratified within-subject (CV I ) and between-subjects (CV G ) BV estimates were determined for 21 CBC parameters. For leukocyte parameters, with the exception of lymphocytes and basophils, significant differences were found between female/male CV I estimates. The mean values of all erythrocyte-, reticulocyte- and platelet parameters differed significantly between the sexes, except for mean corpuscular hemoglobin concentration, mean corpuscular volume and platelet numbers. Most CV I and CV G estimates appear to be lower than those previously published. Our study, based on a rigorous protocol, provides updated and more stringent BV estimates for CBC parameters. Sex stratification of data is necessary when exploring the significance of changes in consecutive results and when setting analytical performance specifications. {\circledC} 2018 Walter de Gruyter GmbH, Berlin/Boston.",
author = "A Coşkun and A Carobene and M Kilercik and M Serteser and S Sandberg and AK Aarsand and P Fernandez-Calle and N Jonker and WA Bartlett and J D{\'i}az-Garz{\'o}n and S Huet and C Klzlltaş and I Dalgaklran and E Ugur and I Unsal and Variation, {on behalf of the European Biological Variation Study of the EFLM Working Group on Biological}",
year = "2018",
doi = "10.1515/cclm-2017-1155",
language = "English",
volume = "56",
pages = "1309--1318",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "8",

}

TY - JOUR

T1 - Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects

AU - Coşkun, A

AU - Carobene, A

AU - Kilercik, M

AU - Serteser, M

AU - Sandberg, S

AU - Aarsand, AK

AU - Fernandez-Calle, P

AU - Jonker, N

AU - Bartlett, WA

AU - Díaz-Garzón, J

AU - Huet, S

AU - Klzlltaş, C

AU - Dalgaklran, I

AU - Ugur, E

AU - Unsal, I

AU - Variation, on behalf of the European Biological Variation Study of the EFLM Working Group on Biological

PY - 2018

Y1 - 2018

N2 - The complete blood count (CBC) is used to evaluate health status in the contexts of various clinical situations such as anemia, infection, inflammation, trauma, malignancies, etc. To ensure safe clinical application of the CBC, reliable biological variation (BV) data are required. The study aim was to define the BVs of CBC parameters employing a strict protocol. Blood samples, drawn from 30 healthy subjects (17 females, 13 males) once weekly for 10 weeks, were analyzed using a Sysmex XN 3000 instrument. The data were assessed for normality, trends, outliers and variance homogeneity prior to coefficient of variation (CV)-analysis of variance (ANOVA). Sex-stratified within-subject (CV I ) and between-subjects (CV G ) BV estimates were determined for 21 CBC parameters. For leukocyte parameters, with the exception of lymphocytes and basophils, significant differences were found between female/male CV I estimates. The mean values of all erythrocyte-, reticulocyte- and platelet parameters differed significantly between the sexes, except for mean corpuscular hemoglobin concentration, mean corpuscular volume and platelet numbers. Most CV I and CV G estimates appear to be lower than those previously published. Our study, based on a rigorous protocol, provides updated and more stringent BV estimates for CBC parameters. Sex stratification of data is necessary when exploring the significance of changes in consecutive results and when setting analytical performance specifications. © 2018 Walter de Gruyter GmbH, Berlin/Boston.

AB - The complete blood count (CBC) is used to evaluate health status in the contexts of various clinical situations such as anemia, infection, inflammation, trauma, malignancies, etc. To ensure safe clinical application of the CBC, reliable biological variation (BV) data are required. The study aim was to define the BVs of CBC parameters employing a strict protocol. Blood samples, drawn from 30 healthy subjects (17 females, 13 males) once weekly for 10 weeks, were analyzed using a Sysmex XN 3000 instrument. The data were assessed for normality, trends, outliers and variance homogeneity prior to coefficient of variation (CV)-analysis of variance (ANOVA). Sex-stratified within-subject (CV I ) and between-subjects (CV G ) BV estimates were determined for 21 CBC parameters. For leukocyte parameters, with the exception of lymphocytes and basophils, significant differences were found between female/male CV I estimates. The mean values of all erythrocyte-, reticulocyte- and platelet parameters differed significantly between the sexes, except for mean corpuscular hemoglobin concentration, mean corpuscular volume and platelet numbers. Most CV I and CV G estimates appear to be lower than those previously published. Our study, based on a rigorous protocol, provides updated and more stringent BV estimates for CBC parameters. Sex stratification of data is necessary when exploring the significance of changes in consecutive results and when setting analytical performance specifications. © 2018 Walter de Gruyter GmbH, Berlin/Boston.

U2 - 10.1515/cclm-2017-1155

DO - 10.1515/cclm-2017-1155

M3 - Article

VL - 56

SP - 1309

EP - 1318

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 8

ER -